252
Participants
Start Date
September 14, 2023
Primary Completion Date
July 31, 2028
Study Completion Date
December 31, 2028
Semaglutide Pen Injector
maintenance dose of 1mg SC once weekly
Semaglutide placebo
maintenance dose of 1mg SC once weekly
RECRUITING
OLV-Aalst-Asse, Aalst
RECRUITING
UZA, Antwerp
RECRUITING
ZNA,, Antwerp
RECRUITING
AZ St Jan Brugge, Bruges
RECRUITING
Erasme, Brussels
RECRUITING
UZ Brussel, Brussels
RECRUITING
Jan Yperman, Ieper
RECRUITING
AZ Groeninge Kortrijk, Kortrijk
RECRUITING
UZ Leuven, Leuven
RECRUITING
CHU de Liège, Liège
RECRUITING
Centre Hospitalier Mouscron, Mouscron
RECRUITING
Vitaz, Sint-Niklaas
RECRUITING
AZ Turnhout, Turnhout
University Hospital, Antwerp
OTHER
Universitair Ziekenhuis Brussel
OTHER
General Hospital Groeninge
OTHER
Onze Lieve Vrouw Hospital
OTHER
Jessa Hospital
OTHER
Ziekenhuis Netwerk Antwerpen (ZNA)
OTHER
Vitaz
OTHER
Centre Hospitalier Universitaire de Liege
OTHER
Erasme University Hospital
OTHER
Centre Hospitalier Mouscron
UNKNOWN
Jan Yperman Ziekenhuis
OTHER
AZ Turnhout
OTHER
AZ Sint-Lucas Brugge
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER